This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Cranial nerves
CD2_BENIGN_CRANIAL_NERVE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum nervi cranialis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Cranial nerves
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Cranial nerves
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1011 | 570 | 441 |
| Unadjusted period prevalence (%) | 0.19 | 0.19 | 0.19 |
| Median age at first event (years) | 56.65 | 55.49 | 58.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 896
- Matched controls
- 8958
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
323.0
744
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
78.8
243.5
271
49
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
236.2
216
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
75.0
168.8
190
32
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
19.0
138.0
220
151
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
11.8
124.9
249
283
DFF00
NOMESCO Finland
Pure tone audiometry
8.8
123.3
298
479
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
43.0
98.9
123
33
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
85.8
81
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
84.7
80
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
189.9
83.7
86
5
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
82.6
78
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
82.6
78
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.1
76.2
284
746
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.6
72.6
308
920
H02AB02
ATC
dexamethasone; systemic
30.5
71.4
96
35
DFF15
NOMESCO Finland
Speech audiometry
7.8
59.7
146
217
WF002
NOMESCO Finland
Radical radiotherapy
130.7
57.6
61
5
DFF59
NOMESCO Finland
Other assessment of balance
25.8
55.6
78
33
G51.0
ICD-10 Finland
Bell palsy
13.0
54.0
98
84
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
52.6
50
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
146.2
52.4
55
*
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
49.4
47
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
47.3
45
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
242.0
45.4
46
*
115
Kela drug reimbursment
Breast cancer
+∞
45.2
43
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
45.1
109
157
N07CA01
ATC
betahistine; oral
5.1
43.4
148
333
130
Kela drug reimbursment
Malignant tumour
+∞
42.0
40
*
PJA12
NOMESCO Finland
Sentinel node biopsy
426.2
41.5
41
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
11.6
40.1
76
71
AAE34
NOMESCO Finland
Other operations on acoustical nerv
+∞
38.8
37
*
H02.2
ICD-10 Finland
Lagophthalmos
57.7
37.7
44
8
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
382.4
37.3
37
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
36.7
35
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.6
35.9
71
72
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
34.6
33
*
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
34.6
33
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
77.2
33.1
37
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
121.2
32.9
35
*
2152
FHL
Extraction, big brain
+∞
32.5
31
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
117.6
31.9
34
*
116
Kela drug reimbursment
Prostate cancer
+∞
31.4
30
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.4
29
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
15.5
30.4
50
34
WF003
NOMESCO Finland
Adjuvant radiotherapy
301.2
28.9
29
*
WF099
NOMESCO Finland
Other radiotherapy
82.9
28.9
32
*
H93.1
ICD-10 Finland
Tinnitus
4.2
28.1
113
296
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
290.0
27.9
28
*
A04AA02
ATC
granisetron; systemic, transdermal
103.3
27.8
30
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
27.6
267
1299
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
278.9
26.9
27
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
26.5
193
794
UDC00
NOMESCO Finland
Ear microscopy
3.9
26.0
114
322
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
139.0
25.7
27
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
24.9
120
367
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
23.5
24.0
34
15
ZX050
NOMESCO Finland
Stereotactic radiotherapy
128.4
23.7
25
*
ZXC40
NOMESCO Finland
Use of ultrasound
31.0
22.9
30
10
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.3
22.3
70
141
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
22.0
21
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
17.1
21.1
33
20
AA1AD
NOMESCO Finland
CT of head and brain
2.2
20.9
257
1374
L02BA01
ATC
tamoxifen; oral
78.7
20.8
23
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
20.6
137
526
L02AE02
ATC
leuprorelin; implant, parenteral
33.4
20.3
26
8
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
20.0
406
2657
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
107.4
19.6
21
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.4
19.6
99
313
HAB40
NOMESCO Finland
Wedge excision of mammary gland
25.2
19.6
27
11
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.2
19.2
43
55
R5120
NOMESCO Finland
Preparation of an aid
5.9
19.0
54
97
HAC20
NOMESCO Finland
Total mastectomy
102.2
18.6
20
*
R42
ICD-10 Finland
Dizziness and giddiness
2.1
18.2
237
1288
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
53.6
18.0
21
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
17.8
17
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.4
17.7
54
106
ZZC00
NOMESCO Finland
Graft of fascia
97.0
17.6
19
*
R4110
NOMESCO Finland
Physiotherapy
2.1
17.2
246
1388
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
16.7
16
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
L02BG04
ATC
letrozole; oral
11.9
16.6
30
26
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
91.8
16.6
18
*
Z31.5
ICD-10 Finland
Genetic counselling
5.3
15.7
48
95
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
L01BC06
ATC
capecitabine; oral
+∞
15.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
162.7
15.5
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
162.7
15.5
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
15.5
176
895
WX402
NOMESCO Finland
General anaesthesia
2.4
15.3
139
634
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
15.2
251
1487
C50.99
ICD-10 Finland
Breast, unspecified
+∞
14.6
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
152.3
14.5
15
*
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.8
14.2
60
164
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
13.6
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
34.6
13.5
17
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
142.0
13.5
14
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
142.0
13.5
14
*
CBH25
NOMESCO Finland
Tarsorrhaphy
142.0
13.5
14
*
CBH30
NOMESCO Finland
Tarsorraphy
142.0
13.5
14
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.6
13.2
45
101
WX110
NOMESCO Finland
Local anesthesy
1.7
13.1
573
4561
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.1
12.9
31
45
A04AA01
ATC
ondansetron; systemic, rectal
5.5
12.8
37
69
NK6AN
NOMESCO Finland
Total body bone isotope imaging
32.5
12.6
16
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.5
12
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
12.5
12
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.5
12
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
131.7
12.5
13
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.3
12.4
32
52
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
3.2
12.4
65
213
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.8
12.3
34
60
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
12.3
122
576
ZXA05
NOMESCO Finland
Left side
1.8
12.0
230
1416
HA1AA
NOMESCO Finland
X-ray mammography
4.3
12.0
44
107
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
47.3
11.9
14
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.5
11.7
34
64
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
16.7
11.7
18
11
QAJ10
NOMESCO Finland
Browlift
16.7
11.7
18
11
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.0
11.7
28
41
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
65.8
11.6
13
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
11.6
211
1275
JN4BD
NOMESCO Finland
Extensive body CT
3.2
11.6
60
195
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
3252
FHL
Repair with foreign material (spring, magnet)
+∞
11.5
11
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
11.5
11
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
11.5
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
121.5
11.4
12
*
L03AA13
ATC
pegfilgrastim; parenteral
121.5
11.4
12
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
17.3
11.2
17
10
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
43.9
10.9
13
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.0
10.5
28
48
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
111.2
10.4
11
*
Y77
ICPC
Malignant neoplasm prostate
111.2
10.4
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
CBW99
NOMESCO Finland
Other operation on eyelid
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
19.0
10.3
15
8
G91.1
ICD-10 Finland
Obstructive hydrocephalus
11.4
10.1
18
16
AAH50
NOMESCO Finland
Cranial nerve anastomosis
55.6
9.7
11
*
DAX08
NOMESCO Finland
Fitting of hearing aid
2.8
9.7
60
220
ZXA00
NOMESCO Finland
Right side
1.7
9.6
233
1531
H02
ICPC
Hearing complaint
2.0
9.6
123
649
H02.1
ICD-10 Finland
Ectropion of eyelid
10.2
9.5
18
18
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
9.4
103
508
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
101.0
9.4
10
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
17.7
9.4
14
8
ZZF00
NOMESCO Finland
Graft of adipose tissue
17.7
9.4
14
8
X76
ICPC
Malignant neoplasm breast female
+∞
9.4
9
*
ZZK00
NOMESCO Finland
Graft of nerve
+∞
9.4
9
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.9
9.3
56
203
N03AF01
ATC
carbamazepine; oral, rectal
2.8
9.1
58
217
D32.05
ICD-10 Finland
Cerebral meninges
37.1
9.0
11
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
37.1
9.0
11
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
37.1
9.0
11
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
24.3
8.9
12
5
H47.1
ICD-10 Finland
Papilloedema, unspecified
12.7
8.9
15
12
N03AF02
ATC
oxcarbazepine; oral
3.8
8.8
36
98
S18
ICPC
Laceration/cut
1.6
8.8
349
2601
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.7
731
6496
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
50.5
8.7
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
8.3
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.0
8.3
32
83
JN4CD
NOMESCO Finland
Very extensive body CT
4.6
8.2
27
60
SPAT1153
SPAT
Removal of sutures
1.6
8.2
273
1943
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.2
8.1
17
21
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
6.9
8.1
19
28
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
22.2
8.0
11
5
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
22.2
8.0
11
5
TAB00
NOMESCO Finland
Lumbar puncture
2.9
7.9
46
163
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.9
7.8
14
13
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
45.4
7.7
9
*
H81.0
ICD-10 Finland
Ménière disease
3.7
7.7
32
89
KCD02
NOMESCO Finland
Transurethral resection of bladder
18.5
7.6
11
6
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
25.2
7.6
10
*
CBF99
NOMESCO Finland
Other operation for ectropion
25.2
7.6
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
8.9
7.6
15
17
XCK00
NOMESCO Finland
Perimetry
2.3
7.5
67
303
G50.1
ICD-10 Finland
Atypical facial pain
4.9
7.5
23
48
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
5.1
7.4
22
44
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
80.7
7.4
8
*
N76
ICPC
Neoplasm nervous system unspecified
80.7
7.4
8
*
DC1AD
NOMESCO Finland
Temporalbone CT
6.0
7.4
19
32
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.7
7.4
20
36
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
+∞
7.3
7
*
2159
FHL
Other measure in this category
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
3259
FHL
Other measure in this category
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
2151
FHL
Resection, big brain
+∞
7.3
7
*
A02BC02
ATC
pantoprazole; systemic
1.5
7.3
532
4466
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
7.3
44
162
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
15.9
7.2
11
7
L03AA02
ATC
filgrastim; parenteral
30.3
7.2
9
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
20.2
7.1
10
5
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
20.2
7.1
10
5
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
7.0
33
102
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.9
7.0
27
71
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.8
6.8
16
24
RK520
NOMESCO Finland
NA
11.0
6.8
12
11
R51.80
ICD-10 Finland
Headache
1.8
6.8
119
704
A79
ICPC
Malignancy NOS
40.3
6.8
8
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
40.3
6.8
8
*
CBK10
NOMESCO Finland
Operation for lagophtalmus
40.3
6.8
8
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
16.8
6.8
10
6
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
4.8
6.7
21
45
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.5
136
848
QAJ20
NOMESCO Finland
Subperiosteal facelift
70.3
6.4
7
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
70.3
6.4
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.3
6.4
7
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
4.1
6.4
23
57
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.0
6.3
16
27
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
9560/0-C71.9
ICD-O-3
Schwannoma, NOS, of brain, NOS
+∞
6.3
6
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
6.3
6
*
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
6.3
6
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
26.9
6.2
8
*
RK320
NOMESCO Finland
NA
7.1
6.2
14
20
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
6.2
92
516
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.3
6.1
21
50
RK110
NOMESCO Finland
NA
7.7
6.1
13
17
Z51.5
ICD-10 Finland
Palliative care
3.6
6.1
25
70
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
12.6
6.1
10
8
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
6.0
49
213
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
41
14.95
64.32
1.8
1.9
—
—
—
0
0
528
3564
2.01
25.69
6.3
5.1
1.2
1.2
mmol/l
0.34
488
3151
300
1735
2.04
21.81
1.9
2.1
—
—
—
0
0
553
3943
1.89
21.37
7.0
5.6
1.2
1.2
mmol/l
0.29
485
3342
494
3463
1.83
19.51
3.6
3.6
—
—
—
0
0
520
3825
1.74
16.41
5.8
3.8
12.2
12.0
umol/l
0.10
499
3582
618
4775
1.76
16.34
5.1
4.2
6.6
6.8
mmol/l
1.96
596
4442
104
434
2.56
16.32
3.9
1.5
15.0
3.6
ug/l
0.66
84
333
167
899
2.03
14.20
7.2
6.5
0.8
1.3
mmol/l
0.68
120
704
166
902
2.01
13.73
7.2
6.5
5.1
5.1
kpa
0.05
157
869
166
902
2.01
13.73
7.2
6.5
15.9
11.7
kpa
11.98
156
868
725
6129
1.65
11.22
7.6
5.4
78.1
75.6
u/l
0.67
684
5674
548
4377
1.55
10.46
8.5
6.6
4.2
4.2
e9/l
0.16
461
3794
436
3328
1.55
10.11
4.2
3.7
35.8
35.8
g/l
0.07
403
3066
904
8205
1.96
9.98
15.1
12.4
24.9
22.8
mg/l
0.94
735
6336
110
591
1.97
9.28
2.4
2.4
28.4
21.2
au/ml
—
8
22
101
528
2.01
9.21
1.3
1.3
19.0
44.5
au/ml
—
5
23
50
198
2.60
8.76
1.9
1.3
2161.9
729.9
e6/l
0.33
42
164
50
198
2.60
8.76
1.7
1.2
83.2
49.5
e6/l
0.19
39
158
936
8673
2.07
8.60
18.3
14.8
139.9
139.8
mmol/l
0.73
920
8438
340
2559
1.50
7.94
3.4
2.0
2.4
2.4
mmol/l
0.16
280
2135
935
8703
1.99
7.82
18.5
14.9
4.0
4.0
mmol/l
2.79
918
8450
177
1175
1.61
7.20
3.2
2.6
0.8
0.8
mmol/l
0.35
166
1091
17
38
4.53
7.19
2.2
1.3
—
—
—
0
0
859
7868
1.61
6.76
15.0
11.2
79.7
78.8
ml/min/173m2
0.63
727
6333
107
656
1.71
5.90
4.4
6.6
9.1
9.7
mmol/l
0.42
101
623
202
1450
1.49
5.71
3.0
2.1
2.5
2.4
mmol/l
0.94
171
1250
116
738
1.65
5.56
4.3
2.9
242.0
236.5
u/l
0.14
105
691
422
3489
1.36
5.28
2.4
2.3
78.9
78.1
nmol/l
0.27
373
3072
150
1032
1.53
5.17
4.6
5.0
1.0
1.0
mmol/l
0.41
140
943
938
8900
1.75
5.07
11.1
9.0
25.8
25.7
u/l
0.10
911
8540
696
6235
1.37
5.07
4.0
4.2
11.4
11.7
mm/h
0.19
637
5735
9
9
10.08
5.03
1.2
1.1
—
—
—
0
0
272
2110
1.40
5.00
3.3
3.0
0.4
0.4
e6/l
0.03
201
1584
206
1522
1.44
4.98
3.4
2.7
0.7
0.7
ug/l
0.11
139
997
599
5251
1.35
4.98
4.8
4.4
711.2
2113.8
e6/l
—
10
71
307
2458
1.36
4.59
3.4
2.7
36.3
32.1
u/l
0.44
291
2334
27
112
2.45
4.41
1.1
1.3
—
—
—
0
0
7
6
11.74
4.28
2.4
1.0
30.5
14.2
u/ml
—
7
6
165
1209
1.44
4.14
2.9
2.7
2.4
2.5
e6/l
0.12
86
644
592
5264
1.30
4.03
3.2
3.0
47.4
46.8
u/l
0.07
554
4870
176
1314
1.41
3.98
2.8
2.6
1.3
1.2
e6/l
0.11
94
746
961
9256
1.77
3.88
23.1
18.5
134.7
136.2
g/l
2.62
954
9095
32
153
2.13
3.82
1.6
1.3
13.3
9.8
u/l
0.39
20
129
76
487
1.61
3.60
2.3
2.3
11.9
14.9
nmol/l
2.27
65
429
827
7759
1.36
3.52
4.9
4.8
1.9
2.1
mu/l
0.81
748
7064
542
4818
1.27
3.46
2.7
2.7
—
—
—
0
0
73
476
1.58
3.23
1.5
1.6
—
—
—
0
0
320
2687
1.28
3.21
2.3
2.2
179.2
230.2
u/l
0.81
306
2520
36
195
1.88
3.10
1.5
1.6
—
—
—
0
0
132
982
1.40
3.05
2.2
2.6
23.9
23.3
%
0.11
110
834
50
301
1.70
3.04
1.3
1.7
—
—
—
0
0
5
5
10.04
2.98
2.6
2.0
58.4
60.0
pmol/l
—
5
5
5
5
10.04
2.98
2.0
1.2
—
—
—
0
0
14
52
2.72
2.89
1.1
1.1
—
—
—
0
0
319
2707
1.26
2.89
5.7
3.8
3.4
1.9
ug/l
0.83
284
2425
11
36
3.08
2.81
1.1
1.3
—
—
—
0
0
85
593
1.47
2.79
2.2
2.0
0.2
0.2
g/l
1.25
79
539
294
2483
1.26
2.75
2.5
2.3
62.9
57.9
u/l
0.40
271
2274
199
1601
1.30
2.75
2.7
2.4
5.0
6.2
e6/l
0.71
171
1400
141
1081
1.35
2.72
2.1
2.4
2.3
2.3
g/l
0.10
125
1004
410
3598
1.23
2.71
2.1
2.0
95.2
95.8
pmol/l
0.09
220
1801
262
2188
1.27
2.69
4.8
3.7
22.6
23.7
%
0.59
139
1018
14
55
2.57
2.62
1.7
1.8
19.1
19.0
nmol/l
0.02
14
48
160
1263
1.32
2.53
1.6
1.8
—
—
—
0
0
46
287
1.63
2.49
1.3
1.6
—
—
—
0
0
94
686
1.41
2.45
2.7
2.3
32.4
42.2
u/l
0.59
82
572
53
350
1.54
2.29
2.5
2.0
36.6
39.7
u/l
0.48
46
309
37
225
1.67
2.24
4.2
1.4
51.5
42.8
mg/l
0.28
29
185
37
225
1.67
2.24
4.3
1.4
36.1
56.2
mg/l
0.33
29
185
6
14
4.30
2.15
1.5
1.1
—
—
—
0
0
721
6796
1.21
2.05
19.2
14.9
13.7
13.6
%
0.27
711
6621
148
1191
1.28
2.05
2.1
2.4
12.8
13.4
umol/l
0.29
132
1094
16
76
2.12
2.03
1.0
1.1
—
—
—
0
0
17
85
2.02
1.91
1.0
1.1
—
—
—
0
0
686
6456
1.19
1.90
4.1
4.0
14.9
14.9
pmol/l
0.04
618
5862
21
115
1.84
1.84
1.4
1.4
249.6
337.7
pmol/l
1.15
16
84
783
7478
1.21
1.76
17.7
13.7
40.1
39.9
%
0.27
573
5141
239
2064
1.21
1.75
1.5
1.5
21.4
21.2
nmol/l
0.06
190
1735
234
2027
1.20
1.66
2.2
2.2
3.0
2.9
mg/l
0.12
198
1709
69
524
1.34
1.49
3.5
3.7
5.0
5.2
kpa
2.05
60
490
5
129
0.38
1.49
1.4
1.6
—
—
—
0
0
102
820
1.27
1.46
2.6
2.3
7.2
7.1
umol/l
0.02
94
707
40
281
1.44
1.38
1.9
1.8
2.3
1.8
ug/l
0.17
34
247
16
89
1.81
1.37
1.0
1.1
—
—
—
0
0
9
41
2.21
1.37
3.1
3.0
27.7
30.9
umol/l
—
9
27
18
105
1.73
1.33
1.7
1.5
—
—
—
0
0
13
68
1.92
1.33
1.6
1.7
—
—
—
0
0
15
253
0.59
1.25
1.3
1.6
—
—
—
0
0
433
4025
1.13
1.17
3.8
3.7
0.0
0.0
estimate
0.50
77
670
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
428
3981
1.13
1.14
5.2
4.9
0.0
0.0
estimate
0.50
76
693
10
51
1.97
1.11
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
41
1.96
1.09
1.0
1.2
—
—
—
0
0
63
498
1.28
1.08
3.6
3.7
0.8
1.8
mmol/l
2.55
49
371
25
169
1.49
1.08
2.1
2.1
130.5
131.2
g/l
0.04
17
125
15
89
1.70
1.08
1.7
1.6
—
—
—
0
0
33
236
1.41
1.08
1.5
1.4
—
—
—
0
0
18
113
1.60
1.06
1.3
1.2
1.8
2.3
u/ml
—
8
36
7
33
2.13
1.05
1.3
2.4
1.0
7.9
nmol/l
—
7
25
64
509
1.27
1.05
1.4
1.5
—
—
—
0
0
353
3261
1.13
1.04
3.5
3.7
40.1
65.6
ng/l
0.52
247
2283
9
47
1.92
1.02
1.8
6.9
—
76.5
—
0
15
10
53
1.90
1.01
1.1
1.0
—
—
—
0
0
83
686
1.23
0.99
2.7
2.2
60.6
66.9
ml/min/173m2
0.83
34
279
44
336
1.32
0.98
3.7
4.1
24.4
24.8
mmol/l
0.53
39
314
28
198
1.43
0.98
2.0
1.6
299.5
273.8
mu/l
0.27
28
176
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
423
3961
1.12
0.98
3.8
3.6
0.0
0.0
estimate
0.00
71
688
7
36
1.95
0.97
1.4
1.7
—
—
—
0
0
7
36
1.95
0.97
1.4
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
216
1.40
0.96
2.7
2.7
0.3
0.4
u/ml
0.35
20
128
128
1107
1.18
0.96
5.0
4.8
32.3
32.6
%
0.13
77
725
56
445
1.27
0.95
2.5
3.1
4.6
4.5
pmol/l
0.08
51
383
9
51
1.77
0.94
1.8
1.7
—
—
—
0
0
17
110
1.55
0.91
1.4
1.2
1.6
5.8
u/ml
—
9
51
35
263
1.34
0.89
4.4
1.3
1.0
0.3
g/l
0.65
26
231
14
87
1.62
0.88
1.0
1.2
—
—
—
0
0
860
8411
1.15
0.86
4.6
4.6
1.5
1.5
mmol/l
0.51
779
7719
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
6
33
1.82
0.79
3.3
2.2
—
—
—
0
0
16
106
1.52
0.79
1.3
1.1
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
264.2
—
0
17
20
140
1.44
0.77
1.6
1.5
—
—
—
0
0
365
3428
1.10
0.77
2.8
2.7
126.9
121.1
ug/l
0.11
333
3134
865
8480
1.14
0.75
4.6
4.7
4.7
4.6
mmol/l
0.98
792
7821
23
167
1.39
0.74
1.3
1.5
—
—
—
0
0
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
28
211
1.34
0.72
1.3
1.5
298.1
316.0
ug/g
0.20
17
125
86
740
1.18
0.72
2.9
1.8
361.2
361.0
nmol/l
0.00
78
677
40
318
1.27
0.71
1.6
1.7
1.7
1.5
g/l
0.85
34
277
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
102
896
1.15
0.67
1.6
1.7
—
—
—
0
0
12
78
1.54
0.65
3.3
1.7
7.6
54.6
u/ml
0.44
12
73
21
154
1.37
0.65
2.4
2.3
15.8
16.3
%
0.17
12
74
102
900
1.15
0.64
1.6
1.8
—
—
—
0
0
29
225
1.30
0.63
1.6
1.8
—
—
—
0
0
18
130
1.39
0.61
1.5
1.5
—
—
—
0
0
22
289
0.76
0.61
1.7
2.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
0.8
—
0
14
90
791
1.15
0.60
3.4
3.0
—
—
—
0
0
20
148
1.36
0.60
1.6
1.5
—
—
—
0
0
26
201
1.30
0.59
3.2
3.1
22.9
25.2
mmol/l
2.36
19
180
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
6
36
1.67
0.56
1.0
1.3
—
—
—
0
0
31
248
1.26
0.55
3.1
1.3
37.8
37.9
g/l
0.05
24
212
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
6
37
1.63
0.55
1.7
1.5
—
—
—
0
0
27
213
1.27
0.54
1.5
1.7
11157.3
11169.2
e6/l
0.00
22
163
14
99
1.42
0.54
1.1
1.0
2.7
3.0
u/ml
—
6
43
20
151
1.33
0.54
1.9
1.8
—
—
—
0
0
876
8631
1.11
0.53
5.2
5.2
2.8
2.7
mmol/l
0.99
796
7929
24
187
1.29
0.53
5.5
3.2
1.6
1.5
mg/l
0.08
19
167
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
25
197
1.28
0.51
1.4
1.3
—
—
—
0
0
71
623
1.15
0.51
3.5
1.6
65.4
67.2
g/l
0.85
58
564
27
335
0.80
0.50
1.1
1.3
0.2
0.6
u/ml
—
7
26
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
71
802
0.88
0.48
2.7
2.5
6.2
7.8
ug/l
0.78
60
709
177
1646
1.09
0.47
3.7
3.9
122.7
422.4
ng/l
3.05
145
1293
26
321
0.80
0.47
1.4
1.7
1.2
2.8
mg/l
2.29
19
225
55
477
1.16
0.46
1.3
1.5
—
—
—
0
0
31
255
1.22
0.46
1.7
1.6
0.0
0.1
iu/ml
—
5
50
827
8141
1.09
0.46
4.1
4.1
1.3
1.3
mmol/l
0.54
735
7398
178
1659
1.09
0.45
1.7
1.7
1098.3
1176.2
nmol/l
0.56
132
1243
13
175
0.74
0.45
1.3
1.5
—
—
—
0
0
30
247
1.22
0.44
1.1
1.4
—
—
—
0
0
24
193
1.25
0.43
4.1
2.8
1.5
1.6
mmol/l
0.10
24
186
23
184
1.26
0.43
4.2
2.9
7.8
7.5
mmol/l
0.16
23
178
133
1439
0.91
0.43
1.3
1.3
33.7
13.5
u/ml
0.32
49
547
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
33
392
0.84
0.42
1.0
1.0
—
—
—
0
0
124
1143
1.10
0.41
1.2
1.4
—
—
—
0
0
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
27.0
—
0
16
20
247
0.81
0.38
2.8
3.1
—
—
—
0
0
24
197
1.22
0.38
1.1
1.1
—
—
—
0
0
9
68
1.33
0.37
3.0
2.2
—
—
—
0
0
12
90
1.34
0.36
1.3
1.2
—
—
—
0
0
14
179
0.78
0.35
3.1
3.5
13.7
26.3
mg/l
—
7
114
15
117
1.29
0.35
2.2
2.3
3.9
4.1
mmol/l
1.33
15
117
15
117
1.29
0.35
2.2
2.3
106.7
105.5
mmol/l
0.52
15
117
34
292
1.17
0.35
3.0
1.3
9.7
10.6
g/l
0.58
27
248
12
91
1.32
0.34
1.2
1.2
—
—
—
0
0
12
91
1.32
0.34
1.3
1.2
—
—
—
0
0
67
739
0.90
0.33
2.9
3.0
126.7
206.1
ng/l
1.68
59
681
227
2164
1.06
0.33
2.4
2.4
352.7
6137.7
umol/l
7.00
195
1852
805
7951
1.06
0.31
6.0
6.1
39.3
40.2
mmol/mol
1.90
728
7367
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
16
129
1.24
0.30
1.8
2.2
3866.7
2377.9
u/l
—
8
57
12
93
1.29
0.30
1.3
1.2
—
—
—
0
0
12
93
1.29
0.30
1.3
1.2
—
—
—
0
0
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
318
3073
1.05
0.29
4.1
3.8
—
—
—
0
0
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
20
167
1.20
0.28
1.2
1.4
—
—
—
0
0
8
63
1.27
0.27
1.6
1.4
—
—
—
0
0
120
1130
1.07
0.27
7.0
6.7
—
—
—
0
0
845
8368
1.06
0.27
4.9
4.8
5.8
6.0
mmol/l
3.61
752
7603
22
187
1.18
0.26
1.4
1.2
—
7.3
—
0
14
13
104
1.25
0.26
1.2
1.1
—
—
—
0
0
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
130
1230
1.07
0.26
1.4
1.4
—
—
—
0
0
22
188
1.17
0.25
1.2
1.3
119.6
231.3
miu/ml
—
7
89
20
234
0.85
0.25
3.0
2.2
83.6
111.3
ug/min
0.23
13
144
33
293
1.13
0.24
3.1
1.3
3.2
3.1
g/l
0.25
25
231
178
1857
0.95
0.24
3.9
4.0
1.0
1.0
kg/l
0.27
22
263
35
313
1.12
0.23
3.1
1.3
7.5
7.4
g/l
0.12
25
236
35
313
1.12
0.23
3.1
1.3
3.5
3.9
g/l
1.09
24
228
35
313
1.12
0.23
3.1
1.3
—
—
—
0
0
11
88
1.25
0.22
2.4
2.7
—
463.9
—
0
11
14
116
1.21
0.22
1.7
1.3
—
—
—
0
0
5
41
1.22
0.22
2.0
1.4
—
—
—
0
0
13
107
1.22
0.21
1.1
1.3
6.1
7.8
mmol/l
—
8
72
119
1131
1.06
0.21
19.0
26.6
1.5
1.3
inr
0.40
12
152
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
0.5
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
14.2
—
0
10
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
4.8
—
—
—
0
0
228
2356
0.96
0.21
1.6
1.6
1.3
1.4
mmol/l
0.36
195
1973
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
18
206
0.87
0.18
1.4
1.9
2.7
4.6
iu/l
—
7
72
279
2860
0.97
0.18
3.8
4.0
16.5
7.9
mg/mmol
0.36
162
1785
34
310
1.10
0.17
4.4
4.0
1.4
1.4
mmol/l
0.01
34
303
5
67
0.75
0.17
1.2
1.2
—
—
—
0
0
19
167
1.14
0.17
1.2
1.4
—
—
—
0
0
207
2131
0.96
0.17
4.5
4.0
0.0
0.0
estimate
0.69
76
676
10
120
0.83
0.16
1.0
1.1
—
17.0
—
0
8
8
71
1.13
0.16
1.6
1.4
—
—
—
0
0
39
419
0.93
0.14
3.3
2.8
25.6
25.3
mmol/l
0.25
39
405
8
98
0.81
0.13
1.3
1.4
—
—
—
0
0
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
8
99
0.81
0.13
1.3
1.4
—
—
—
0
0
50
530
0.94
0.13
1.2
1.2
142.2
143.3
iu/ml
0.01
19
222
52
549
0.94
0.12
1.6
1.8
—
—
—
0
0
280
2849
0.98
0.11
2.9
3.1
7.6
7.4
mmol/l
0.35
235
2403
19
209
0.91
0.11
1.2
1.3
—
—
—
0
0
12
105
1.14
0.11
2.1
1.8
—
—
—
0
0
25
231
1.08
0.10
1.8
1.5
—
—
—
0
0
5
44
1.14
0.10
1.6
1.3
—
—
—
0
0
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
70
675
1.04
0.09
4.2
3.6
91.1
87.1
ng/l
0.12
60
587
5
60
0.83
0.08
1.6
1.6
—
—
—
0
0
37
389
0.95
0.08
1.2
1.3
—
—
—
0
0
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
6
75
0.80
0.07
1.0
1.5
—
—
—
0
0
8
77
1.04
0.07
1.4
1.2
—
—
—
0
0
25
235
1.07
0.07
1.1
1.1
—
—
—
0
0
10
112
0.89
0.07
1.0
1.0
—
—
—
0
0
9
87
1.03
0.07
1.7
1.4
—
—
—
0
0
14
128
1.10
0.06
1.5
1.2
198.4
256.1
u/ml
—
9
73
51
527
0.97
0.06
4.0
2.8
132.9
130.2
g/l
0.43
51
512
171
1735
0.98
0.06
1.7
1.7
1.3
1.2
mg/l
0.04
123
1320
25
237
1.06
0.05
1.1
1.1
—
—
—
0
0
10
90
1.11
0.05
1.6
1.4
—
—
—
0
0
22
231
0.95
0.04
1.8
1.8
—
—
—
0
0
181
1791
1.01
0.04
1.3
1.3
1.0
1.8
u/ml
1.04
40
474
17
161
1.06
0.03
1.2
1.3
—
—
—
0
0
91
898
1.01
0.02
2.2
1.7
1.4
1.5
%
0.55
81
766
251
2525
0.99
0.02
2.7
2.9
1396.4
1275.3
ng/l
0.15
218
2144
146
1473
0.99
0.02
1.4
1.3
57.3
33.9
iu/ml
0.75
43
471
189
1900
0.99
0.01
1.6
1.7
441.2
30122464.6
pmol/l
1.92
149
1557
40
393
1.02
0.01
3.3
2.4
0.7
0.7
%
0.62
40
379
10
96
1.04
0.00
1.0
1.3
—
—
—
0
0
11
108
1.02
0.00
1.3
1.5
—
—
—
0
0
11
113
0.97
0.00
1.5
1.5
—
—
—
0
0
14
137
1.02
0.00
1.4
1.2
—
—
—
0
0
13
127
1.02
0.00
1.0
1.1
—
—
—
0
0
15
147
1.02
0.00
6.1
3.3
4.7
4.3
e9/l
0.12
15
147
15
149
1.01
0.00
6.7
3.6
56.3
57.7
%
0.11
15
149
38
383
0.99
0.00
4.7
3.4
46.2
50.0
%
0.41
38
378
61
613
0.99
0.00
1.7
1.9
—
—
—
0
0
67
667
1.00
0.00
2.1
1.8
—
—
—
0
0
28
285
0.98
0.00
1.9
1.9
—
—
—
0
0
22
215
1.02
0.00
1.3
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
0.00
1.7
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
11.7
—
0
5
75
750
1.00
0.00
3.8
3.2
1.9
2.1
mmol/l
0.13
65
600
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
8
81
0.99
0.00
4.3
3.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
9.7
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CRANIAL_NERVE_EXALLC – Benign neoplasm: Cranial nerves
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).